Generics BulletinAmneal says the planned portfolio of its glucagon-like peptide-1 (GLP-1) agonist collaboration partner Metsera is “moving swiftly through the drug development phase,” as the US-based firm noted that t
Pink SheetAfter another loss in the US Court of Appeals, Teva will seek a certiorari review by the US Supreme Court of its long-running inhaler patent case against Amneal . Teva had requested a full panel re
Generics BulletinTeva has suffered another nth blow in its long-running inhaler patent case against Amneal, as the US Court of Appeals for the Federal Circuit denied the Israeli firm’s request for an en banc reheari
Generics BulletinApproved by the US Food and Drug Administration only in August last year, Amneal’s Crexont (carbidopa/levodopa) extended-release capsules for Parkinson’s disease has “exceeded expectations” in its ear